Edico Genome

About:

Edico Genome revolutionizes genome sequencing analysis by providing unprecedented speed, scale, and accuracy.

Top Investors: Qualcomm Ventures, Dell Technologies Capital, EvoNexus, Moore Venture Partners, FusionX Ventures

Description:

Edico Genome develops bioinformatics processor chips for DNA analysis designed to analyze sequencing data. The company's DRAGEN platform uses a field-programmable gate array to provide hardware-accelerated implementations of genome pipeline algorithms, such as BCL conversion, compression, mapping, alignment, sorting, duplicate marking, and haplotype variant calling, enabling healthcare institutions to easily discover links between DNA sequence variations and human disease.

Total Funding Amount:

$32M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Diego, California, United States

Founded Date:

2013-01-01

Contact Email:

info(AT)edicogenome.com

Founders:

Pieter van Rooyen

Number of Employees:

11-50

Last Funding Date:

2017-05-09

IPO Status:

Private

Industries: